Table 2.

Incidence of morbidity due to CanL, before and after the use of DMC

Locations	Number of dogs	Symptomatic dogs		p -value	Power of the test
		1993-2001	2002-2012		(α = 0.05)
Toulon/Hyères	46	10 (21.7%)	0 (0%)	< 0.001	92%
Solenzara	34	7 (20.5%)	2 (5.9%)	> 0.05	40%
Total	80	17 (21.2%)	2 (2.5%)	< 0.0001	97%